“Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study”, J. Anal. Oncol., vol. 2, no. 3, pp.  128–134, Aug. 2013, doi: 10.6000/1927-7229.2013.02.03.1.